The Center faculty come from all four UCSF schools and conduct research and teaching in every aspect of tobacco control, from efforts by the tobacco industry to manipulate international politics to the molecular biology of nicotine addiction.
Associate Vice Chancellor, Clinical and Translational Science Institute
Dr. Jennifer R. Grandis received her medical degree from the University of Pittsburgh School of Medicine, Pennsylvania, and completed her internship from the same institution. Dr. Grandis completed both a residency and an Infectious Disease fellowship from the University of Pittsburgh School of Medicine, Pennsylvania. Prior to joining UCSF, Dr. Grandis was the UPMC Endowed Chair in Head and Neck Cancer Surgical Research and Distinguished Professor of Otolaryngology and Pharmacology and Chemical Biology at the University of Pittsburgh.
Research on health promotion, including tobacco control, with particular emphasis on knowledge dissemination, transfer, program planning and implementation strategies. His interest is in making practice more evidence-based by making evidence more practice-based. Dr. Green has been the PI on research grants and on predoctoral and postdoctoral training grants from NIH,, the VA , CDC, AHRQ, and the Canadian Institute for Health Research.
Valerie Gribben, MD, FAAP is an Assistant Professor of Pediatrics at UCSF. Research interests include: reducing primary and secondhand vaping, cigarette, and marijuana exposure in children and teens; vaping patterns of teenagers during the COVID-19 pandemic; the intersection between digital usage and vaping; social media interventions to assist in vaping cessation; and health disparities in tobacco use and exposure.
Dian Gu, PhD, received her doctorate in Health Economics/Health Services Research from the University of Texas Health Science Center at Houston. Along with her PhD study, she was a PhD trainee in MD Anderson Cancer Center. In that role, she gained experience in applying health economics to cancer research, collaborating on manuscripts with clinicians on multiple projects concerned with cancer patients’ healthcare utilization, expenditures, and health outcomes.
Research on access, delivery, and organization of substance abuse treatment services, treatment effectiveness, and adoption of new treatments into practice settings. He is currently testing an organizational change intervention for treatment programs in tobacco dependence. Joseph Guydish, PhD, MPH, is Professor of Medicine and Health Policy at the University of California, San Francisco. His research concerns access, delivery, and organization of substance abuse treatment services.
Major areas of research are clinical trials for the treatment of nicotine dependence, with emphasis on treatments that reflect a chronic disease model, and on complex populations. Dr. Hall's research is on the treatment of drug abuse, especially tobacco dependence, and better understanding the processes of change through randomized clinical trials and related studies. She is especially interested in the treatment of comorbidities in special populations, and the complexities that comorbidities introduce into treatment.
Deanna M. Halliday, PhD, received her doctorate in Psychological Sciences (Health Psychology) from the University of California, Merced under the mentorship of UCSF alumna Dr. Anna Song. Prior to joining the CTCRE, she was awarded a TRDRP pre-doctoral fellowship for her dissertation work on tobacco and cannabis co-use. Her work examines the multi-level factors that contribute to tobacco and cannabis use spanning from internal psychological factors to social and community-level factors. Dr.
Eileen Han, PhD, received her doctorate in Communication from the Annenberg School for Communication, University of Pennsylvania. During and after her PhD studies, she mainly conducted qualitative research about social media, with a focus on collective memory and social activism. She published a book about social media and collective memory in China, which was an expansion of her dissertation research.
Mark Hawes, MSW, PhD, received his doctorate in Social Work from Washington University in St. Louis, Brown School of Social Work where he was funded by the NIMH as a T32 Pre-Doctoral Fellow. During his time at the Brown School, he was affiliated with the Center for Mental Health Services Research, worked on projects aiming to reduce health inequities among people with serious mental illness, and co-taught a gradate course on behavioral health policy and services.
My research program is focused on basic and translational research on sepsis and other forms of inflammation-driven acute organ failure ("Inflammatory Critical Illness"). Sepsis and multiple organ failure are leading causes of death in the Intensive Care Unit. These processes result from a complex inflammatory response that is initiated through the innate immune system by interactions between host cells and microbes or endogenous host factors that are released during injury or cell death.
Major goals: To use an integrated, interdisciplinary approach to obtain evidence about key aspects of the translation of genomic information for breast and colorectal cancer into clinical practice and health policy.